Identification of a Novel and Selective Series of Itk Inhibitors via a Template-Hopping Strategy.
Alder, C.M., Ambler, M., Campbell, A.J., Champigny, A.C., Deakin, A.M., Harling, J.D., Harris, C.A., Longstaff, T., Lynn, S., Maxwell, A.C., Mooney, C.J., Scullion, C., Singh, O.M., Smith, I.E., Somers, D.O., Tame, C.J., Wayne, G., Wilson, C., Woolven, J.M.(2013) ACS Med Chem Lett 4: 948-952
- PubMed: 24900590 
- DOI: 10.1021/ml400206q
- Primary Citation of Related Structures:  
4L7S - PubMed Abstract: 
Inhibition of Itk potentially constitutes a novel, nonsteroidal treatment for asthma and other T-cell mediated diseases. In-house kinase cross-screening resulted in the identification of an aminopyrazole-based series of Itk inhibitors. Initial work on this series highlighted selectivity issues with several other kinases, particularly AurA and AurB ...